Bill Title: Enacts the pharmaceutical cost transparency act requiring prescription drug manufacturers to file a report disclosing certain financial information pertaining to prescription drugs which have a wholesale acquisition cost of $10,000 or more annually or per course of treatment.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2017-03-03 - REFERRED TO HEALTH [S04986 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	2017-03-03	HTML/Text	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for New York S04986

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for New York S04986 currently on file.

Social Comments on NY S04986